drugset / Trial / NCT03186456
The Safety and Efficacy of Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-ACI) in the Treatment of Acute Cerebral Infarction
RandomizedParallel-groupDouble-blindTreatment
Summary
The purposes of the study is to determine the safety and efficacy of treating acute ischemic stroke patients with human umbilical cord mesenchymal stem cells (hUC-MSC).
Timeline
- Start
- 2026-12-31
- Primary completion
- 2027-06-30
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic umbilical cord mesenchymal stem cells | Cell therapy | 500000 cells/kg | Intravenous |
| Subject | Allogeneic umbilical cord mesenchymal stem cells | Cell therapy | 1e+06 cells/kg | Intravenous |
| Background | Aspirin | Small molecule | 100 mg | — |